Stimulated resistin expression in white adipose of rats with bile duct ligation-induced liver cirrhosis: Relationship to cirrhotic hyperinsulinemia and increased tumor necrosis factor-alpha

Molecular and Cellular Endocrinology

Volumn 232, Issue 1-2, 2005, Pages 1-8

  Lin, Shih Yi ^a,d   Sheu, Wayne Huey Herng ^a   Chen, Wen Yin ^a   Lee, Fa Yauh ^b   Huang, Ching Jang ^c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Hyperinsulinemia; Liver cirrhosis; Resistin; Tumor necrosis factor

Indexed keywords

FAT; MESSENGER RNA; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; GENE EXPRESSION; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN SENSITIVITY; LIVER CIRRHOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; UPREGULATION; WHITE ADIPOSE TISSUE;

EID: 14344265507     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2005.01.006     Document Type: Article

References (44)

1. M. Ader, and R.N. Bergman Insulin sensitivity in the intact organism Balliere's Clin. Endocrinol. Metab. 1 1988 879 910
2. R.R. Banerjee, S.M. Rangwala, J.S. Shapiro, A.S. Rich, B. Rhoades, Y. Qi, J. Wang, M.W. Rajala, A. Pocai, P.E. Shere, C.M. Steppan, R.S. Ahima, S. Obici, L. Rossetti, and M.A. Lazar Regulation of fasted blood glucose by resistin Science 303 2004 1195 1198
3. G.P. Chrousos The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation N. Engl. J. Med. 332 1995 1351 1363
4. D.H.G. Crawford, R.W. Shepherd, J.W. Halliday, G.W.E. Cooksley, S.D. Golding, W.S.C. Cheng, and L.W. Powell Body composition in nonalcoholic cirrhosis: the effects of disease etiology and severity on nutritional compartment Gastroenterology 106 1994 1611 1617
5. M.R.K. Dasu, L. LaGrone, and W.J. Mileski Alterations in resistin expression after thermal injury J. Trauma 56 2004 118 122
6. A. Donaghy, R. Ross, C. Wicks, S.C. Hughes, J. Holly, A. Gimson, and R. Williams Growth hormone therapy in patients with cirrhosis: a pilot study of efficacy and safety Gastroenterology 113 1997 1617 1622
7. M. Farrer, G.R. Fulcher, A.J. Johnson, C.O. Record, and K.G.M.M. Albert Effects of acute inhibition of lipolysis on operation of the glucose-fatty acid cycle in hepatic cirrhosis Metabolism 41 1992 465 470
8. M. Fasshauer, J. Klein, S. Neumann, M. Eszlinger, and R. Paschke Tumor necrosis factor α is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes Biochem. Biophys. Res. Commun. 288 2001 1027 1031
9. B.N. Finck, and R.W. Johnson Anti-inflammatory agents inhibit the induction of leptin by tumor necrosis factor-α Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 2002 R1429 R1435
10. H. Fujita, H. Fujishima, T. Morri, J. Koshimura, T. Narita, M. Kakei, and S. Ito Effect of metformin on adipose tissue resistin expression in db/db mice Biochem. Biophys. Res. Commun. 298 2002 345 349
11. J.H. Green, P.N. Bramley, and M.S. Losowsky Are patients with primary biliary cirrhosis hypermetabolic? A comparison between patients before and after liver transplantation and controls Hepatology 14 1991 464 472
12. F. Haugen, A. Jorgensen, C.A. Drevon, and P. Trayhurn Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes FEBS Lett. 507 2001 105 108
13. S. Kaser, A. Kaser, A. Sandhofer, C.F. Ebenbichler, H. Tilg, and J.R. Patsch Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro FEBS Lett. 309 2003 190 286
14. J. Kawashima, K. Tsuruzoe, H. Motoshima, A. Shirakami, K. Sakai, Y. Hirashima, T. Toyonaga, and E. Araki Insulin down-regulates resistin mRNA through synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes Diabetologia 46 2003 231 240
15. K.H. Kim, K. Lee, Y.S. Moon, and H.S. Sul A cysteine-rich adipose-tissue specific secretory factor inhibits adipocyte differentiation J. Biol. Chem. 276 2001 11252 11256
16. K.H. Kim, L. Zhao, Y. Moon, C. Kang, and H.S. Sul Dominant inhibitory adipocyte-specific factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity Proc. Natl. Acad. Sci. U.S.A. 101 2004 6780 6785
17. J. Kontouras, B.H. Billing, and P.J. Scheurer Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat Br. J. Exp. Pathol. 65 1984 305 311
18. L. Krahenbuhl, C. Talos, J. Reichen, and S. Krahenbuhl Progressive decreased in tissue glycogen content in rats with long-term cholestasis Hepatology 24 1996 902 907
19. A.S. Lihn, B. Richelsen, S.B. Pedersen, S.B. Haugaard, G.S. Rathje, S. Madsbad, and O. Andersen Increased expression of TNF-α, IL-6, and IL-8 in HALS implications for reduced adiponectin expression and plasma levels Am. J. Physiol. Endocrinol. Metab. 285 2003 E1072 E1080
20. S.Y. Lin, Y.Y. Wang, and W.H.H. Sheu Increased serum leptin concentrations correlate with soluble tumor necrosis factor receptor levels in liver patients with liver cirrhosis Clin. Endocrinol. 57 2002 805 811
21. S.Y. Lin, Y.Y. Wang, and W.H.H. Sheu Increased serum soluble tumor necrosis factor receptors levels are associated with insulin resistance in liver cirrhosis Metabolism 53 2004 922 926
22. Lin, S.Y., Chen, W.Y., Lee, F.Y., Huang, C.J., Sheu, W.H.H., in press. Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of tumor necrosis factor-α. Am. J. Physiol. Endocrinol. Metab.
23. H. Liu, Z. Ma, and S.S. Lee Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats Gastroenterology 118 2001 937 944
24. S.C. Lu, W.Y. Shieh, C.Y. Chen, S.C. Hsu, and H.L. Chen Lipopolysaccharide increases resistin gene expression in vivo and in vitro FEBS Lett. 530 2002 158 162
25. P.G. McTernan, C.L. McTernan, R. Chetty, K. Jenner, F.M. Fisher, M.N. Lauer, J. Crocker, A.H. Barnett, and S. Kumar Increased resistin gene and protein expression in human abdominal adipose tissue J. Clin. Endocrinol. Metab. 87 2002 2407 2410
26. G.B. Moore, H. Chapman, J.C. Holder, C.A. Lister, V. Piercy, S.A. Smith, and J.C. Clapham Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice Biochem. Biophys. Res. Commun. 286 2001 735 741
27. M.J. Muller Malnutrition in cirrhosis J. Hepatol. 23 Suppl. 1 1995 31 35
28. E.D. Muse, S. Obici, S. Bhanot, B.P. Monia, R.A. McKay, M.W. Rajala, P.E. Scherer, and L. Rossetti Role of resistin in diet-induced hepatic insulin resistance J. Clin. Invest. 114 2004 232 239
29. M. Neuman, P. Angulo, I. Malkiewicz, R. Jorgensen, N. Shear, E.R. Dickson, J. Haber, G. Katz, and K. Lindor Tumor necrosis factor-α and transforming growth factor-β reflect severity of liver damage in primary biliary cirrhosis J. Gastroentrol. Hepatol. 17 2002 196 202
30. W. Nolte, H. Hartmann, and G. Ramadori Glucose metabolism and liver cirrhosis Exp. Clin. Endocrinol. Diabetes 103 1995 63 74
31. A. Petrides, T. Stanley, D.E. Matthews, C. Vogt, A.J. Bush, and H. Lambeth Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity Hepatology 28 1998 141 149
32. M. Pravenec, L. Kazdova, V. Landa, V. Zidek, P. Mleknek, P. Jansa, J. Wang, N. Qi, and T.W. Kurtz Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rats J. Biol. Chem. 278 2003 45209 45215
33. M.W. Rajala, Y. Lin, M. Ranalletta, X.M. Yang, H. Qian, R. Gingerich, N. Barzilai, and P.E. Scherer Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-α in adipose tissue Mol. Endocrinol. 16 2002 1920 1930
34. M.W. Rajala, Y. Qi, H.R. Patel, N. Takahashi, R. Banerjee, U.B. Pajvani, M.K. Sinha, R.L. Gingerich, P.E. Scherer, and R.S. Ahima Regulation of resistin expression and circulating levels in obesity, diabetes and feeding Diabetes 53 2004 1671 1679
35. C.P. Sewter, J.E. Digby, F. Blows, J. Prins, and S. O'Rahilly Regulation of tumor necrosis factor-alpha from human adipose in vitro J. Endocrinol. 163 1999 33 38
36. G.K. Shetty, P.A. Economides, E.S. Horton, C.S. Mantzoros, and A. Veves Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, vascular reactivity in diabetic patients and subjects at risk for diabetes Diabetes Care 27 2004 2340 2457
37. N. Shojima, H. Sakoda, T. Ogihara, M. Fujishiro, H. Katagiri, M. Anai, Y. Onishi, H. Ono, K. Inukai, M. Abe, Y. Fukushima, M. Kikuchi, Y. Oka, and T. Asano Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells Diabetes 51 2002 1737 1744
38. C.M. Steppan, S.T. Bailey, S. Bhat, E.J. Brown, R.B. Banerjee, C.M. Wright, H.R. Patel, R.S. Ahima, and M.A. Lazar The hormone resistin links obesity to diabetes Nature 409 2001 307 312
39. C.M. Steppan, and M.A. Lazar The current biology of resistin J. Int. Med. 255 2004 439 447
40. R. Taylor, R.J. Heine, J. Collins, O.F.W. James, and K.G.M.M. Alberti Insulin action in cirrhosis Hepatology 5 1985 64 71
41. H. Tilg, A. Wilmer, W. Vogel, M. Herold, B. Nolchen, G. Judmaier, and C. Huber Serum levels of cytokines in chronic liver diseases Gastroenterology 103 1992 264 274
42. J.P. Warne Tumor necrosis factor α: a key regulatory of adipose tissue mass J. Endocrinol. 177 2003 351 355
43. J.M. Way, C.Z. Gorgun, Q. Tong, K.T. Uysal, K.K. Brown, W.W. Harrington, W.R. Oliver Jr., T.M. Wilson, S.A. Kliewer, and G.S. Hotamisligil Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor γ agonists J. Biol. Chem. 276 2001 25651 25653
44. Q. Zhong, C.Y. Lin, K.J. Clarke, R.J. Kemppainen, D.D. Schwartz, and R.L. Judd Endothelin-1 inhibits resistin secretion in 3T3-L1 adipocytes Biochem. Biophys. Res. Commun. 296 2002 383 387